<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Human Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Human Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Физиология человека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0131-1646</issn><issn publication-format="electronic">3034-6150</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">664090</article-id><article-id pub-id-type="doi">10.31857/S0131164624060062</article-id><article-id pub-id-type="edn">AGCYWK</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Association of the Polymorphic Marker rs1614148 of the EGLN1 Gene with Aerobic Capacity of Athletes</article-title><trans-title-group xml:lang="ru"><trans-title>Ассоциация полиморфного маркера rs1614148 гена EGLN1 с аэробными возможностями спортсменов</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dautova</surname><given-names>A. Z.</given-names></name><name xml:lang="ru"><surname>Даутова</surname><given-names>А. З.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Valeeva</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Валеева</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Semenova</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Семенова</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mavliev</surname><given-names>F. A.</given-names></name><name xml:lang="ru"><surname>Мавлиев</surname><given-names>Ф. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zverev</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Зверев</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nazarenko</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Назаренко</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Larin</surname><given-names>A. K.</given-names></name><name xml:lang="ru"><surname>Ларин</surname><given-names>А. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Generozov</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Генерозов</surname><given-names>Э. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ahmetov</surname><given-names>I. I.</given-names></name><name xml:lang="ru"><surname>Ахметов</surname><given-names>И. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>dautova.az@mail.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Volga Region State University of Physical Culture, Sport and Tourism</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Поволжский государственный университет физической культуры, спорта и туризма</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Казанский государственный медицинский университет Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Lopukhin federal research and clinical center of physical-chemical medicine of federal medical biological agency</institution></aff><aff><institution xml:lang="ru">ФГБУ Федеральный научно-клинический центр физико-химической медицины имени академика Ю М. Лопухина Федерального медико-биологического агентства</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Liverpool John Moores University</institution></aff><aff><institution xml:lang="ru">НИИ спорта Ливерпульского университета имени Джона Мурса</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-12" publication-format="electronic"><day>12</day><month>12</month><year>2024</year></pub-date><volume>50</volume><issue>6</issue><fpage>52</fpage><lpage>60</lpage><history><date date-type="received" iso-8601-date="2025-02-25"><day>25</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0131-1646/article/view/664090">https://journals.eco-vector.com/0131-1646/article/view/664090</self-uri><abstract xml:lang="en"><p>Recent studies have shown an association between the rs1614148 polymorphism of the Egl-9 family hypoxia-inducible factor 1 (<italic>EGLN1</italic>) gene and maximal oxygen consumption (VO<sub>2</sub>) in untrained individuals. The association of this polymorphism with aerobic performance in athletes and with haematological parameters has not been previously investigated. The aim of this study was to investigate the association of the polymorphic marker rs1614148 of the <italic>EGLN1</italic> gene with aerobic performance and haematological parameters in athletes of different specialisations and qualifications. 1309 athletes specialised in different sports were studied (538 females 21.9 ± 4.1 years, 771 males 22.4 ± 4.8 years). At the time of the survey, 132 athletes had the qualification of Honoured Master of Sports (HMS), 331 – International Master of Sports (IMS), 444 – Master of Sports (MS), 257 – Candidate Master of Sports (CMS) and 145 – popular sports categories. The control group consisted of 284 non-athletes (44.5 ± 4.1 years). DNA was isolated from buccal epithelial cells or from venous blood leukocytes. Genotyping was performed by real-time PCR or microarray analysis. Athletes were assessed for aerobic performance using spiroergometry (n = 259) and haematological parameters were determined (n = 240). A predominance of the rs1614148*A allele was found both in highly qualified athletes and in the general group of endurance athletes (stayers) compared to speed athletes (26.3% versus 15.8%, χ<sup>2</sup> = 3.81, OR = 1.90, p = 0.025). An association of the rs1614148 AA genotype of the <italic>EGLN1</italic> gene with higher BMD (p = 0.047) was observed in the IMS and HMS group, which is consistent with literature data. No effect of the <italic>EGLN1</italic> gene polymorphism on haematological parameters was found. Thus, the rs1614148*A allele predominates in the group of stayers, which may be due to its association with high aerobic capacity.</p></abstract><trans-abstract xml:lang="ru"><p>Недавние исследования показали ассоциацию полиморфизма rs1614148 гена фактора, индуцируемого гипоксией 1 семейства Egl-9 (<italic>EGLN1</italic>) с максимальным потреблением кислорода (МПК) у нетренированных лиц. Изучение ассоциации данного полиморфизма с аэробной работоспособностью у спортсменов, а также с гематологическими показателями ранее не проводилось. Целью исследования явилось изучение ассоциации полиморфного маркера rs1614148 гена <italic>EGLN1 </italic>с аэробной работоспособностью и гематологическими показателями спортсменов разной специализации и квалификации. Было обследовано 1309 спортсменов, специализирующихся в различных видах спорта (538 женщин 21.9 ± 4.1 лет, 771 мужчина 22.4 ± 4.8 лет). На момент обследования 132 спортсмена имели квалификацию заслуженного мастера спорта (ЗМС), 331 – мастера спорта международного класса (МСМК), 444 – мастера спорта (МС), 257 – кандидата в мастера спорта (КМС) и 145 – массовые спортивные разряды. Группу сравнения составили 284 чел., не занимающихся спортом (44.5 ± 4.1 лет). ДНК выделяли из клеток буккального эпителия либо лейкоцитов венозной крови. Генотипирование проводили с помощью ПЦР в реальном времени, либо микрочипового анализа. У спортсменов проводили оценку аэробной работоспособности с помощью спироэргометрии (<italic>n</italic> = 259), а также определяли значения гематологических параметров (<italic>n</italic> = 240). Обнаружено<bold> </bold>преобладание rs1614148*A аллеля как среди высококвалифицированных спортсменов, так и в общей группе спортсменов, тренирующих выносливость (стайеров), по сравнению со спортсменами скоростно-силовой направленности (26.3% против 15.8%, χ<sup>2<italic> </italic></sup>= 3.81, отношение шансов<italic> </italic>(<italic>Odds Ratio</italic>,<italic> OR</italic>) <italic>OR</italic> = 1.90, <italic>p</italic> = 0.025). У стайеров уровня МСМК и ЗМС установлена ассоциация генотипа rs1614148 AA гена <italic>EGLN1 </italic>с более высоким МПК (<italic>р</italic> = 0.047), что соответствует данным литературы. Влияние полиморфизма гена <italic>EGLN1</italic> на гематологические показатели обнаружено не было. Таким образом, rs1614148*A аллель превалирует в группе стайеров, что может быть обусловлено его ассоциацией с высокими аэробными возможностями.</p></trans-abstract><kwd-group xml:lang="en"><kwd>polymorphism</kwd><kwd>gene</kwd><kwd>genotype</kwd><kwd>hypoxia</kwd><kwd>endurance</kwd><kwd>hematological parameters</kwd><kwd>maximum oxygen consumption</kwd><kwd>highly skilled athletes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>полиморфизм</kwd><kwd>ген</kwd><kwd>генотип</kwd><kwd>гипоксия</kwd><kwd>выносливость</kwd><kwd>гематологические показатели</kwd><kwd>максимальное потребление кислорода</kwd><kwd>высококвалифицированные спортсмены</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Правительство РФ</institution></institution-wrap><institution-wrap><institution xml:lang="en">Government of the Russian Federation</institution></institution-wrap></funding-source><award-id>123100600294-2</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dempsey J.A., Wagner P.D. Exercise-induced arterial hypoxemia // J. Appl. Physiol. 1999. V. 87. № 6. P. 1997.</mixed-citation></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Popov D.V., Vinogradova O.L. [Aerobic performance: role of oxygen delivery and utilization, glycolytic flux] // Usp. Fiziol. Nauk. 2012. V. 43. № 1. P. 30.</mixed-citation><mixed-citation xml:lang="ru">Попов Д.В., Виноградова О.Л. Аэробная работоспособность: роль доставки кислорода, его утилизации и активации гликолиза // Успехи физиологических наук. 2012. Т. 43. № 1. С. 30.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><mixed-citation>Nielsen H.B., Bredmose P.P., Stromstad M. et al. Bicarbonate attenuates arterial desaturation during maximal exercise in humans // J. Appl. Physiol. 2002. V. 93. № 2. P. 724.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vogiatzis I., Georgiadou O., Giannopoulou I. et al. Effects of exercise-induced arterial hypoxaemia and work rate on diaphragmatic fatigue in highly trained endurance athletes // J. Physiol. 2006. V. 572. Pt. 2. P. 539.</mixed-citation></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Grataloup O., Busso T., Castells J. et al. Evidence of decrease in peak heart rate in acute hypoxia: Effect of exercise-induced arterial hypoxemia // Int. J. Sports. Med. 2007. V. 28. № 3. P. 181.</mixed-citation><mixed-citation xml:lang="ru">Grataloup O., Busso T., Castells J. et al. Evidence of decrease in peak heart rate in acute hypoxia: effect of exercise-induced arterial hypoxemia // Int. J. Sports. Med. 2007. V. 28. № 3. P. 181.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><mixed-citation>Semenza G.L. Oxygen sensing, homeostasis, and disease // N. Engl. J. Med. 2011. V. 365. № 6. P. 537.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension // Proc. Natl. Acad. Sci. U.S.A. 1995. V. 92. № 12. P. 5510.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Semenza G.L. The genomics and genetics of oxygen homeostasis // Annu. Rev. Genomics Hum Genet. 2020. V. 21. P. 183.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Corrado C. Fontana S. Hypoxia and HIF signaling: One axis with divergent effects // Int. J. Mol. Sci. 2020. V. 21. № 16. P. 5611.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bai J., Li L., Li Y., Zhang L. Genetic and immune changes in Tibetan high-altitude populations contribute to biological adaptation to hypoxia // Environ. Health Prev. Med. 2022. V. 27. P. 39.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Lappin T.R., Lee F.S. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis // Blood Rev. 2019. V. 37. P. 100590.</mixed-citation></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Bondareva E.A., Bleer A.N., Godina E.Z. Search for associations between G/A polymorphism of the EPAS1 gene and the maximal oxygen consumption in Russian athletes // Human Physiology. 2016. V. 42. № 3. P. 335.</mixed-citation><mixed-citation xml:lang="ru">Бондарева Э.А., Блеер А.Н., Година Е.З. Поиск ассоциаций G/A – полиморфизма гена EPAS1 с уровнем максимального потребления кислорода у российских спортсменов // Физиология человека. 2016. Т. 42. № 3. С. 120.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><mixed-citation>Brutsaert T.D., Kiyamu M., Elias Revollendo G. et al. Association of EGLN1 gene with high aerobic capacity of Peruvian Quechua at high altitude // Proc. Natl. Acad. Sci. U.S.A. 2019. V. 116. № 48. P. 24006.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Liu G., Zhao W., Zhang H. et al. rs1769793 variant reduces EGLN1 expression in skeletal muscle and hippocampus and contributes to high aerobic capacity in hypoxia // Proc. Natl. Acad. Sci. U.S.A. 2020. V. 117. № 47. P. 29283.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Semenova E.A, Hall E.C.R., Ahmetov I.I. Genes and Athletic Performance: The 2023 Update // Genes (Basel). 2023. V. 14. № 6. P. 1235.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Sutter C.H., Laughner E., Semenza G.L. Hypoxia inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutation // Proc. Natl. Acad. Sci. U.S.A. 2000. V. 97. № 9. P. 4748.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Huang L.E., Gu J., Schau M., Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway // Proc. Natl. Acad. Sci. U.S.A. 1998. V. 95. № 14. P. 7987.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Strocchi S., Reggiani F., Gobbi G. et al. The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation // Oncogene. 2022. V. 41. № 29. P. 3665.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Semenova E.A, Zempo H., Miyamoto-Mikami E. et al. Genome-wide association study Identifies CDKN1A as a novel locus associated with muscle fiber composition // Cells. 2022. V. 11. № 23. P. 3910.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Bouthelier A., Aragonés J. Role of the HIF oxygen sensing pathway in cell defense and proliferation through the control of amino acid metabolism // Biochim. Biophys. Acta Mol. Cell Res. 2020. V. 1867. № 9. P. 118733.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Simonson T.S., Wei G., Wagner H.E. et al. Low hemoglobin concentration in Tibetan males is associated with greater high-altitude exercise capacity // J. Physiol. 2015. V. 593. № 14. P. 3207.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Moore J.A., Hubbi M.E., Wang C. et al. Isolated erythrocytosis associated with 3 novel missense mutations in the EGLN1 gene // J. Investig. Med. High Impact Case Rep. 2020. V. 8. P. 2324709620947256.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Yasukochi Y., Nishimura T., Ugarte J. et al. Effect of EGLN1 genetic polymorphisms on hemoglobin concentration in andean highlanders // Biomed Res. Int. 2020. V. 2020. P. 3436581.</mixed-citation></ref></ref-list></back></article>
